Publications

Vaccine Safety Surveillance in Pregnancy Using Gaia Definitions for Neonatal Conditions: A Feasibility Assessment in Low- and Middle-Income Countries.

Stuurman, AL; Riera, M; Lamprianou, S; Perez-Vilar, S; Anderson, SA; MANGTANI, P; Devlieger, H; Verstraeten, T; Zuber, P; Maure, CG;

2018

DRUG SAFETY, (2018).41 11

The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries.

HOWARD, N; BELL, S; WALLS, H; BLANCHARD, L; Brenzel, L; JIT, M; MOUNIER-JACK, S;

2018

Human vaccines & immunotherapeutics, (2018).14 6 10.1080/21645515.2018.1444321.

NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?.

Preziosi, M-P; GREENWOOD, B;

2018

The Lancet infectious diseases, (2018).18 10 10.1016/S1473-3099(18)30430-4.

Research and development of new tuberculosis vaccines: a review.

Schrager, LK; HARRIS, RC; Vekemans, J;

2018

F1000Research, (2018).7, 10.12688/f1000research.16521.2.

Vaccine mandates, public trust, and vaccine confidence: understanding perceptions is important.

Widdus, R; LARSON, H;

2018

Journal of public health policy, (2018).39 2 10.1057/s41271-017-0117-5.

Prevention of Ebola virus disease through vaccination: where we are in 2018.

Lévy, Y; Lane, C; PIOT, P; Beavogui, AH; Kieh, M; Leigh, B; Doumbia, S; D'Ortenzio, E; Lévy-Marchal, C; Pierson, J; WATSON-JONES, D; Nguyen, V-K; LARSON, H; Lysander, J; Lacabaratz, C; Thiebaut, R; Augier, A; ISHOLA, D; Kennedy, S; Chêne, G; GREENWOOD, B; Neaton, J; Yazdanpanah, Y;

2018

Lancet, (2018).392 10149 10.1016/S0140-6736(18)31710-0.

A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13.

Reglinski, M; Ercoli, G; Plumptre, C; KAY, E; Petersen, FC; Paton, JC; WREN, BW; Brown, JS;

2018

NPJ vaccines, (2018).3 1 10.1038/s41541-018-0090-4.

A bibliometric analysis of systematic reviews on vaccines and immunisation.

FERNANDES, S; JIT, M; BOZZANI, F; GRIFFITHS, UK; SCOTT, JA G; BURCHETT, HE D;

2018

Vaccine, (2018).36 17 10.1016/j.vaccine.2018.02.049.

Choices in vaccine trial design in epidemics of emerging infections.

Kahn, R; Rid, A; SMITH, PG; Eyal, N; Lipsitch, M;

2018

PLoS medicine, (2018).15 8 10.1371/journal.pmed.1002632.

Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.

Hammitt, LL; Etyang, AO; Morpeth, SC; OJAL, J; Mutuku, A; Mturi, N; Moisi, JC; ADETIFA, IM; Karani, A; Akech, DO; OTIENDE, M; Bwanaali, T; Wafula, J; Mataza, C; Mumbo, E; Tabu, C; Knoll, MD; Bauni, E; Marsh, K; Williams, TN; Kamau, T; Sharif, SK; Levine, OS; SCOTT, JA G;

2018

Lancet, (2018).393 10186 10.1016/S0140-6736(18)33005-8.